| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A4D104 | HCG19535; Hypothetical gene supported by AK027125; cDNA FLJ54628; | LOC401307; | NULL | 137 | human |
| Q9NPI2 | Bruton's tyrosine kinase; | NULL | NULL | 174 | human |
| E5FWN9 | ATP synthase subunit a; | ATP6; | NULL | 226 | human |
| Q8N4A4 | Similar to dual specificity phosphatase 9; Fragment; | NULL | NULL | 354 | human |
| D6RIY3 | DCN1-like protein 4; | DCUN1D4; | NULL | 46 | human |
| Q85L04 | Cytochrome c oxidase subunit 3; | COX3; | NULL | 260 | human |
| M0R0M3 | Gamma-glutamylaminecyclotransferase; Fragment; | GGACT; | NULL | 26 | human |
| D3HIC2 | ABO blood group; Transferase A, alpha 1-3-N-acetylgalactosaminyltransferase transferase B, alpha 1-3-galactosyltransferase; Fragment; ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase transferase B, alpha 1-3-galactosyltransferas疏?疐 | ABO; | NULL | 344 | human |
| E9NKC9 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | ND4L; | NULL | 98 | human |
| Q6WQU7 | Lymphotoxin alpha; Fragment; | LTA; | NULL | 66 | human |
| Q0ZCI6 | Immunglobulin heavy chain variable region; Fragment; | NULL | NULL | 122 | human |
| I6VE32 | UDP-glucuronosyltransferase 1-1; EC 2.4.1.17; | BILIQTL1; | NULL | 533 | human |
| G5EA40 | Methyltransferase-like protein 20; Uncharacterized protein; | METTL20; MGC50559; | NULL | 114 | human |
| Q8NBU1 | Serine/threonine-protein kinase 3; cDNA FLJ90748 fis, clone PLACE1011824, highly similar to Human Ste20-like kinase (MST2) mRNA; | STK3; | NULL | 168 | human |
| B0LUF9 | ALDH2; Fragment; | ALDH2; | NULL | 35 | human |
| H8WR10 | Rh blood group D antigen; Rhesus blood group D antigen; Fragment; | RHD; | NULL | 24 | human |
| J3KQ47 | Protein unc-50 homolog; | UNC50; | XP_005263970.1; | 276 | human |
| B6ZDE5 | Thyroid adenoma-associated protein; | THADA; | NULL | 297 | human |
| Q8NHC1 | HCG2002310; Seven transmembrane helix receptor; | NULL | NULL | 335 | human |
| F2Z2H3 | Zinc finger protein 142; | ZNF142; | NULL | 98 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |